Literature DB >> 10922476

Inhibition of inducible nitric oxide synthesis by oxidized lipoprotein(a) in a murine macrophage cell line.

T Moeslinger1, R Friedl, I Volf, M Brunner, E Koller, P G Spieckermann.   

Abstract

Increased plasma levels of human lipoprotein(a) (Lp(a)) are highly correlated with the development of atherosclerotic lesions. During our study, we investigated the effects of native and hypochlorite oxidized lipoprotein(a) (ox-Lp(a)) on nitric oxide production by the inducible nitric oxide synthase (iNOS) in lipopolysaccharide/interferon stimulated mouse macrophages (J774A.1). Ox-Lp(a) (0-2 microg/ml) induces a dose dependent inhibition of inducible nitric oxide synthesis. iNOS protein expression showed a dose dependent reduction as revealed by immunoblotting when cells were incubated with increasing amounts of ox-Lp(a). Ox-Lp(a) decreases iNOS mRNA synthesis as shown by reverse transcription-polymerase chain reaction. Ox-Lp(a) induced iNOS inhibition might contribute to the development of atherosclerotic lesions by reducing the anti-atherogenic effects of nitric oxide.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10922476     DOI: 10.1016/s0014-5793(00)01825-1

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  2 in total

1.  A method for lipoprotein (a) Isolation from a small volume of plasma with applications for clinical research.

Authors:  Paul A Mueller; Elisabeth Yerkes; Paige Bergstrom; Sara Rosario; Joshua Hay; Nathalie Pamir
Journal:  Sci Rep       Date:  2022-06-01       Impact factor: 4.996

2.  Apolipoprotein (a)/Lipoprotein(a)-Induced Oxidative-Inflammatory α7-nAChR/p38 MAPK/IL-6/RhoA-GTP Signaling Axis and M1 Macrophage Polarization Modulate Inflammation-Associated Development of Coronary Artery Spasm.

Authors:  Yen-Kuang Lin; Chi-Tai Yeh; Kuang-Tai Kuo; Iat-Hang Fong; Vijesh Kumar Yadav; Nicholas G Kounis; Patrick Hu; Ming-Yow Hung
Journal:  Oxid Med Cell Longev       Date:  2022-01-19       Impact factor: 6.543

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.